Prostaglandin E2 (PGE2) suppresses apoptosis in multiple cell types, and it has been shown that malignant cells release IL1β, which induces PGE2 synthesis in MSCs, which is followed by the activation of β-catenin signalling and the induction of the cancer stem cell phenotype. This evidence concerns the gene IL1B and cancer.